Search

Background: Cerebrovascular diseases represent the second leading cause of mortality in the world and Brazil occupies the leadership in the ranking of mortality in South America. Objectives: This study sought to analyze the sociodemographic profile and the time trend of the mortality rate from cerebrovascular disease in the Northeast of Brazil, 1996-2016. Methods: This is an ecological study of time series involving deaths from cerebrovascular diseases in the Northeastern of Brazil, 1996-2016. Sociodemographic variables (age, schooling, marital status, skin color, ICD category and federation units) were included and calculated crude and standardized mortality rates, according to gender and age group. A joinpoint regression model was applied for the temporal analysis, with a level of significance of 5%. Results: There were 490.433 deaths from cerebrovascular diseases in the Northeast of Brazil, 1996-2016. Of these deaths, 50,03% (n = 245.354) were women, 79,72% (n = 390.957) elderly, 46,66% (n = 228.851) brown, 51,81% (n = 332.439) illiterate and 37,93% (n = 186.014) were married. Of the causes of death, 56,63% (n = 277.741) resulted from stroke, not specified as hemorrhagic or ischemic (I64). In the Northeast, there was a predominance of the elderly population, with growth of 1.2% (p < 0.001). Conclusions: Standardized mortality increased in four states, being higher in Maranhão and Piauí, with a predominance of females and age equal to or above 60 years.

Introducao: Desde o inicio da pandemia de Covid-19, estudos apontam que pacientes oncologicos representam um dos principais grupos de risco Objetivo: Sintetizar a literatura no que se refere ao perfil clinico-epidemiologico de pacientes oncologicos com Covid-19 Metodo: Revisao integrativa da literatura a partir da base PubMed, utilizando os descritores COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV e coronavirus combinados com cancer, tumor e malignancy Resultados: Dos 821 artigos encontrados, nove textos foram incluidos na analise qualitativa, totalizando 39 individuos, com predominio do sexo masculino (74,4% homens): China (6 textos, 35 pacientes), Nigeria (1 texto, 1 paciente), Franca (1 texto, 2 pacientes) e Dinamarca (1 texto, 1 paciente) Os cânceres de pulmao (51,3%;n=20) e de mama (10,3%;n=4) foram os mais prevalentes Em 87,2% (n=34), nao foram relatadas informacoes sobre habitos de vida Os sintomas respiratorios (46,8%;n=18) e febre (43,6%;n=17) se destacaram Seis pacientes foram a obito (15,4%), quatro receberam alta por cura (10,2%), dois permaneceram internados ate a publicacao do estudo (5,2%) e sobre os demais (69,3%, n=27) o manuscrito nao informava o desfecho Conclusao: O cuidado adequado a esse grupo especial de pacientes quando infectados pelo novo coronavirus e fundamental em busca de melhores desfechos Mais estudos ainda sao necessarios para uma melhor compreensao de como a Covid-19 se comporta em pacientes com câncer Introduction: Since the beginning of COVID-19 pandemic, studies indicate that oncologic patients represent one of the main risk groups Objective: To synthesize the literature addressing clinical and epidemiological profile of oncologic patients with COVID-19 Method: A systematic review of the literature was carried out in the PubMed database, utilizing the descriptors COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV and coronavirus combined with cancer, tumor and malignancy Results: Of the 821 articles found, nine texts were included in the qualitative analysis, totaling 39 individuals, predominantly male (74 4% men): China (6 texts, 35 patients), Nigeria (1 text, 1 patient), France (1 text, 2 patients), Denmark (1 text, 1 patient) Lung (51 3%;n=20) and breast (10 3%;n=4) cancers were the most prevalent In 87 2% (n=34), information about life habits were not reported Respiratory symptoms (46 8%;n=18) and fever (43 6%;n=17) stood out Six patients died (15 4%), four were discharged due to cure (10 2%), two remained hospitalized until the study was published (5 2%) and for the other patients (69 3%, n=27), the manuscript did not inform the outcome Conclusion: Adequate care for this special group of patients when infected with the new coronavirus is essential in pursuing better outcomes Further studies are still needed to better understand how COVID-19 behaves in cancer patients Introduccion: Desde el comienzo de la pandemia de Covid-19, los estudios indican que los pacientes con cancer representan uno de los principales grupos de riesgo Objetivo: Sintetizar la literatura sobre el perfil clinico-epidemiologico de pacientes con cancer ademas de Covid-19 Metodo: Revision integral de la literatura utilizando la base de datos PubMed, con los descriptores COVID-19, SARS-CoV-2, 2019-nCoV, n-CoV y coronavirus combinados con cancer, tumor y malignidad Resultados: De los 821 articulos encontrados, se incluyeron nueve textos en el analisis cualitativo, totalizando 39 individuos, predominantemente hombres (74 4% hombres): China (6 textos, 35 pacientes), Nigeria (1 texto, 1 paciente), Francia (1 texto, 2 pacientes), Dinamarca (1 texto, 1 paciente) Los canceres de pulmon (51,3%;n=20) y de mama (10,3%;n=4) fueron los mas prevalentes En 87,2% (n=34) del total, no se informo ninguna informacion acerca de habitos de vida Se destacaron los sintomas respiratorios (46,8%;n=18) y fiebre (43,6%;n=17) Seis pacientes fallecieron (15,4%), cuatro fueron dados de alta por cura (10,2%), dos permanecieron hospitalizados hasta que se publico el estudio (5,2%) y en los otros (69,3%, n=27) el manuscrito no informo el resultado Conclusion: La atencion adecuada para este grupo especial de pacientes cuando se infectan con el nuevo coronavirus es esencial en la busqueda de mejores resultados Todavia se necesitan mas estudios para comprender mejor como se comporta Covid-19 en pacientes con cancer